Older News Items

4th-October-2021

Personalized closed-loop neuromodulation therapy resulted in a rapid and sustained improvement in depression

22nd-September-2021

Patterns of pre-treatment reward task brain activation predict individual antidepressant response

15th-September-2021

Repurposing anti-cancer drugs to modulate cerebrovascular neoangiogenesis may provide an effective treatment for AD and related vascular diseases of the brain

26th-August-2021

Inflammation in the brain drives the progression from the presence of amyloid plaque and tau tangles to the onset of dementia and Alzheimers disease

18th-August-2021

Key mechanisms behind synapse degeneration in Alzheimer’s brain discovered

30th-July-2021

MIA-690, a novel growth hormone releasing hormone (GHRH) antagonist, exhibits anxiolytic and antidepressant-like effects in mouse model

14th-July-2021

Astrocytic interleukin-3 programs microglia and limits Alzheimer disease

5th-July-2021

Psilocybin ameliorates stress-related behavioral deficit in mice and increases spine density and spine size in frontal cortical pyramidal cells

28th-June-2021

Normal cognition and hippocampal volume are associated with preservation of high soluble A-beta42 levels despite increasing brain amyloidosis

28th-June-2021

Sustained effects of rapidly acting antidepressants require BDNF-dependent MeCP2 phosphorylation

15th-June-2021

Innate immunity stimulation via CpG oligos ameliorates Alzheimers disease pathology in aged squirrel monkeys

9th-June-2021

Calcineurin inhibitor,Tacrolimus, protects against age-associated microstructural changes in the beagle brain

26th-May-2021

Targeted proteasome enhancement reduces post-synaptic Tau

26th-May-2021

Attenuation of mPFC %ΔGlu as an adaptive response to acute stress is impaired in individuals with depression

24th-May-2021

Restoring miR-132 expression rescues adult hippocampal neurogenesis and memory deficits in Alzheimer disease